Animal Models and Their Limits
What animal studies are for, why results in mice, rats or other animals often fail to carry over to people, and how to read a headline built on an animal study.
Content last updated . This page has not been medically reviewed.
What an animal model is
An animal model is a study in which animals, often mice or rats, are given a disease or condition, or a human-like version of it, so researchers can test how a compound or procedure behaves in a living body. Animal work is part of "preclinical research": the studies done before a product is given to people [1]. This page explains what that kind of evidence can and cannot tell you.Why results often do not carry over
- Different biology. A review of animal stroke research found that over 95% of studies used rats and mice, that the animals were almost invariably young and that females were highly underrepresented [5].
- Models that match only part of a disease. A widely used mouse model of amyotrophic lateral sclerosis (ALS) carries a human gene change found in about 3% of patients, so it may be valid only for that subgroup [5].
- Timing and dosing do not match real life. Most animal studies failed to acknowledge the delay between symptom onset and the start of treatment in patients; in one review of animal studies of five stroke drugs, treatment began a median of just 10 minutes after the injury, which the authors called infeasible in the clinic [5].
- Study quality. In a random sample of 2,000 PubMed records, of the animal experiments where randomization would have been appropriate, 27 of 134 (20%) reported it, and 4 of 146 (3%) reported blinded assessment of outcome; none reported a sample size calculation [6]. Reporting is not the same as practice, but the review notes that the largest reported benefits tend to appear in studies meeting the fewest quality checks [6].
- Publication bias. Positive animal results are more likely to be published; for animal stroke studies this may account for a third or more of the efficacy reported [5].
How to read a headline built on an animal study
- Name the species and the model. "In mice" means preclinical (cells/animals only), not "works in people."
- Look for randomization and blinding. Good animal studies describe both [6].
- Ask what was measured. A change in a lab marker is not a health outcome.
- Ask whether human trials exist. If not, the claim is a hypothesis.
- Beware amounts. Doses given to animals are not recommendations for people, and nothing here suggests trying a compound yourself.
Related guides
Cell Studies vs Animal Studies vs Human Trials, Aging in Mice, Worms and Humans: What Transfers and Why Promising Findings Sometimes Fail go further. Where animal studies sit on the full road to approval is in The Translational Pipeline From Laboratory to Approval.Frequently asked questions
Are animal studies useless?
No. They are required background for human trials and can reveal serious harms [1][2]. They are weak at predicting whether a treatment will work in people, as the BMJ comparison shows [3].
Why do mouse studies make so many headlines?
They are faster and cheaper than human trials and are early in the pipeline, so there are many of them. The FDA notes that after early testing only a small number of compounds look promising [8].
Does a mouse result mean a supplement or therapy will work for me?
No. Without human trials the finding is preclinical (cells/animals only), and results in animals have gone in the opposite direction from human results [3]. Ask your clinician before relying on any such claim.
What is replacing animal tests?
The FDA announced a plan to use cell-line and organoid testing and computer models of toxicity to reduce or replace some animal testing for monoclonal antibodies and other drugs [7].
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
How to read the evidence labels
Labels used on this page: preclinical (cells/animals only), established, mixed. This is general education, not medical advice.
Why animal studies are done
Before testing a drug in people, researchers must find out whether it has the potential to cause serious harm [1]. A developer's application to begin human trials must include animal study data and toxicity data [2]. The FDA also says preclinical research is "not a substitute" for studies of how a drug interacts with the human body [2]. Animal studies are a gate, not a verdict.Where animal results and human results disagreed
A systematic review in the BMJ compared animal experiments with human trials for six interventions whose effect in people was already clear [3].| Intervention | What happened in animals | What happened in people |
|---|---|---|
| Corticosteroids for head injury | Benefit (pooled odds ratio for a poor functional outcome 0.58, 95% confidence interval 0.41 to 0.83) | No benefit in trials [3] |
| Tirilazad for stroke | Infarct volume (the size of damaged brain tissue) down 29% (21% to 37%) | Worse outcomes [3] |
| Tissue plasminogen activator for stroke | Infarct volume down 24% (20% to 28%) | Improved outcomes [3] |
So animal results sometimes pointed the same way as human trials and sometimes the opposite way. The authors concluded that disagreement may be due to bias or to animal models failing to mimic the clinical disease adequately [3]. That is the main lesson: an animal result is a hypothesis about people, not a finding about people. A separate review of toxicity testing, written by a critic of current practice, reports that about 12% of pharmaceuticals pass preclinical testing to enter clinical trials and that roughly 89% of novel drugs fail in human trials, about half of those because of unexpected human toxicity [4]. Different authors count these things differently, so treat the exact figures with care.
A changing regulatory picture
References
- U.S. Food and Drug Administration. Step 2: Preclinical Research. Read 2026-10-22.
- U.S. Food and Drug Administration. Step 3: Clinical Research. Read 2026-10-22.
- Perel P, Roberts I, Sena E, et al. Comparison of treatment effects between animal experiments and clinical trials: systematic review. BMJ 2007. Read 2026-10-22.
- Van Norman GA. Limitations of Animal Studies for Predicting Toxicity in Clinical Trials: Is it Time to Rethink Our Current Approach? JACC Basic Transl Sci 2019. Read 2026-10-22.
- van der Worp HB, Howells DW, Sena ES, et al. Can animal models of disease reliably inform human studies? PLoS Med 2010. Read 2026-10-22.
- Macleod MR, Lawson McLean A, Kyriakopoulou A, et al. Risk of Bias in Reports of In Vivo Research: A Focus for Improvement. PLoS Biol 2015. Read 2026-10-22.
- U.S. Food and Drug Administration. FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs (press announcement, April 10, 2025). Read 2026-10-22.
- U.S. Food and Drug Administration. Step 1: Discovery and Development. Read 2026-10-22.